1. The in-use stability of the rituximab biosimilar Rixathon®/Riximyo® upon preparation for intravenous infusion. (March 2019) Authors: Lamanna, William C; Heller, Katharina; Schneider, Daniel; Guerrasio, Raffaele; Hampl, Veronika; Fritsch, Cornelius; Schiestl, Martin Journal: Journal of oncology pharmacy practice Issue: Volume 25:Number 2(2019) Page Start: 269 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗